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Spinal muscular atrophy (SMA) is a neurogenetic autosomal recessive disorder char-
acterized by degeneration of lower motor neurons associated with muscle atrophy and 
paralysis. 
The disease course including onset and severity depends by reduced amounts of the 
survival motor neuron (SMN) protein. Such a protein is increased when the enzyme gly-
cogen synthase kinase-3beta (GSK3beta) is inhibited.
In the present study we used a knockout double transgenic mouse (Smn−/−; 
SMN1A2G; SMN2) modelling SMAIII to dissect the spinal cord pathology at ultrastructur-
al analysis at prolonged survival time (18 months). We analysed the subcellular structure 
of spinal cord motor neurons both in baseline conditions and following the administration 
of a GSK3beta inhibitor.
We found that motor neurons increased their diameter confirming our previous light 
microscopy data. The amount of immunogold labelled SMN particles was dramatically 
reduced in the whole cell body incuding nucleus and cytoplasm. Remarkably, at nuclear 
level we could detect marked reduction of the SMN protein with Cajal-like bodies thus 
mimicking the human disease. In mice receiving long-term lithium administration the 
level of the SMN protein were massively increase way more than other SMAIII mice 
and significantly exceeding the levels counted in controls. When compared with control 
mice administered long-term lithium SMN levels in SMA III mice were overlapping with 
healthy animals, at large. The effects of lithium on ultrastructural morphology of motor 
neurons extended to the preservation of mitochondrial compartment which was slightly 
affected in motor neurons from SMA III mice. These data confirm the essential role of 
GSK3beta inhibition in increasing the amount of the SMN protein and provide a novel 
action for an old drug which increases SMN level exceeding any other compound tested 
so far in this motor neuron pathology. At the same time the beneficial effects of lithium on 
mitochondrial morphology are confirmed.
As an appendix to the present study we wish to mention the ubiquitous nature of these 
effects which were replicated in non-motor neuron cell lines. Apart from the significance in 
cell biology this latter observation provide the basis to analyze the effects of a lithium treat-
ment on affected patients using peripheral or skin-derived cell cultures.
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